Though more and more data indicates that when radiation is COMBINED with other therapies, melanoma patients can reap local, systemic and even abscopal benefits. However, as noted in this previous post: Radiation of lymph node basin not so helpful - if that is all that is done
- radiation alone does not help.
And now there's this:
A retrospective analysis of the role of adjuvant
radiotherapy in the treatment of cutaneous melanoma. Baker, Camacho, Andrews,
Mackley. Cancer Biol Ther. 2016 Aug 15.
Melanoma is a significant
clinical problem, with rising rates of incidence. Surgery is the mainstay of
treatment. The role of adjuvant radiotherapy in the control of locoregionally
advanced cutaneous melanoma is controversial. A retrospective study of the
Surveillance, Epidemiology, and End Results (SEER) database was performed.
Patients with locoregionally confined cutaneous melanoma treated surgically
between 2004 and 2009 were evaluated, with cancer-specific and all-cause
mortality as primary end points. Propensity score matching was used to match
319 radiotherapy patients with 319 non-radiotherapy controls, stratifying by
head and neck (HN) and non-head and neck (NHN) primary. Surgery was primarily
by wide excision in both the radiotherapy (51.72%) and non-radiotherapy
(53.91%) groups. The majority had nodal disease (82.13% vs. 82.44%). White
(91.22% vs. 90.59%) males (70.21% vs. 68.96%) predominated. Average ages at
diagnosis were 62.27 and 63.02. Using Cox proportional
hazards models, radiation conferred decreased survival in all-cause and cancer
specific mortality in combined analysis. The
NHN group showed significantly decreased 6-year cancer specific survival for
radiated patients. The HN group showed a non-significant hazard with
radiotherapy. Meaningful differences not captured in the SEER database may
exist between cohorts. Based on
available SEER data, routine use of adjuvant radiotherapy should be viewed with
caution and reserved for high-risk patients. Future trials evaluating
patient quality of life may clarify the benefit of adjuvant radiotherapy in
high-risk melanoma populations.
Just something to keep in mind!!! - c
Thanks for this. Follow up scans this Thursday 10/13. My nerves are wrecked.
ReplyDelete